Virtus Fund Advisers, LLC Insmed Inc Transaction History

Virtus Fund Advisers, LLC

  • $20.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$16.98 - $23.15 $24,417 - $33,289
1,438 New
1,438 $28,000
Q3 2022

Nov 14, 2022
SELL
$20.88 - $28.21 $239,994 - $324,245
-11,494 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$26.43 - $31.78 $303,786 - $365,279
11,494
11,494 $358,000

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Virtus Fund Advisers, LLC Portfolio

Follow Virtus Fund Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Fund Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus Fund Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email